Yuen MF, Liu SH, Seto WK, Mak LY, et al. Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong. Dig Dis Sci 2020 May 8. pii: 10.1007/s10620-020-06281.
PMID: 32385703